Your browser doesn't support javascript.
loading
Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer.
Cunha, Sara I; Bocci, Matteo; Lövrot, John; Eleftheriou, Nikolas; Roswall, Pernilla; Cordero, Eugenia; Lindström, Linda; Bartoschek, Michael; Haller, B Kristian; Pearsall, R Scott; Mulivor, Aaron W; Kumar, Ravindra; Larsson, Christer; Bergh, Jonas; Pietras, Kristian.
Afiliação
  • Cunha SI; Ludwig Institute for Cancer Research, Uppsala, Sweden. Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Bocci M; Division of Translational Cancer Research, Department of Laboratory Medicine, Medicon Village, Lund University, Lund, Sweden.
  • Lövrot J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Eleftheriou N; Division of Translational Cancer Research, Department of Laboratory Medicine, Medicon Village, Lund University, Lund, Sweden.
  • Roswall P; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Cordero E; Division of Translational Cancer Research, Department of Laboratory Medicine, Medicon Village, Lund University, Lund, Sweden.
  • Lindström L; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Bartoschek M; Division of Translational Cancer Research, Department of Laboratory Medicine, Medicon Village, Lund University, Lund, Sweden.
  • Haller BK; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Pearsall RS; Acceleron Pharma, Cambridge, Massachusetts.
  • Mulivor AW; Acceleron Pharma, Cambridge, Massachusetts.
  • Kumar R; Acceleron Pharma, Cambridge, Massachusetts.
  • Larsson C; Division of Translational Cancer Research, Department of Laboratory Medicine, Medicon Village, Lund University, Lund, Sweden.
  • Bergh J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Pietras K; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. Division of Translational Cancer Research, Department of Laboratory Medicine, Medicon Village, Lund University, Lund, Sweden. Kristian.Pietras@med.lu.se.
Cancer Res ; 75(12): 2445-56, 2015 Jun 15.
Article em En | MEDLINE | ID: mdl-26077471
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Activinas Tipo II / Inibidores de Proteínas Quinases Tipo de estudo: Observational_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Activinas Tipo II / Inibidores de Proteínas Quinases Tipo de estudo: Observational_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia